Nebius ramps up leverage with $5.75B convertible notes as dilution risk rises
Nebius' $5.75B convertible issuance raises balance-sheet and refinancing concerns as annual interest expense consumes a material share of EBITDA. Shareholder authorization to issue up to 20% new shares without preemptive rights, alongside insider net selling, increases dilution risk. Management's guidance that pricing power may persist only 18–24 months and normalize by 2027–2028 further pressures the near-term equity risk premium.
AI Insight · NCSKNBIS2USD/USDTAI Insight
▼ Bearish
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Nebius has issued $5.75B in convertible notes, with annual interest expense exceeding one-quarter of quarterly EBITDA, fueling concerns about its financing position. Shareholders have approved issuing up to 20% new shares without preemptive rights, adding to dilution risk alongside net insider selling. Management said current pricing power may last only 18–24 months and expects normalization in 2027–2028 as supply catches up with demand.